Editorial: Unravelling the role of CB2r in neuropsychiatric diseases

Editorial: Unravelling the role of CB2r in neuropsychiatric diseases

Bibliographic Details
Main Author:	Emmanuel S. Onaivi
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-03-01
Series:	Frontiers in Psychiatry
Subjects:	endocannabinoidome CB2r biomarker neurodegenerative disorders neuropsychiatric disorders
Online Access:	https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1171959/full

Similar Items

New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders
by: Berhanu Geresu Kibret, et al.
Published: (2022-01-01)

Exosomes as Emerging Biomarker Tools in Neurodegenerative and Neuropsychiatric Disorders—A Proteomics Perspective
by: Boby Mathew, et al.
Published: (2021-02-01)

Emerging evidence implicating a role for neurexins in neurodegenerative and neuropsychiatric disorders
by: Katelyn Cuttler, et al.
Published: (2021-10-01)

Advances in the role of the GADD45 family in neurodevelopmental, neurodegenerative, and neuropsychiatric disorders
by: Mengbing Huang, et al.
Published: (2024-01-01)

Multiple Aspects of Inappropriate Action of Renin–Angiotensin, Vasopressin, and Oxytocin Systems in Neuropsychiatric and Neurodegenerative Diseases
by: Ewa Szczepanska-Sadowska, et al.
Published: (2022-02-01)

EVs-mediated delivery of CB2 receptor agonist for Alzheimer's disease therapy
by: Yanjing Zhu, et al.
Published: (2023-07-01)

The Role of Lysophosphatidic Acid in Neuropsychiatric and Neurodegenerative Disorders
by: Simona Dedoni, et al.
Published: (2024-03-01)

Editorial: Therapeutic potential of the cannabinoid CB2 receptor
by: Reem Smoum, et al.
Published: (2022-10-01)

Editorial: Neuropsychiatric and neurodegenerative aspects of acute and long COVID
by: Abbas F. Almulla, et al.
Published: (2023-12-01)

Editorial: Molecular mechanisms of neuropsychiatric diseases
by: Mónica Moreira-Rodrigues, et al.
Published: (2022-12-01)

Role of CB2 cannabinoid receptor in the development of food addiction in male mice
by: A. García-Blanco, et al.
Published: (2023-04-01)

Low Basal CB2R in Dopamine Neurons and Microglia Influences Cannabinoid Tetrad Effects
by: Qing-Rong Liu, et al.
Published: (2020-12-01)

Editorial: Neuroimaging insights into the link between sleep disturbances and neuropsychiatric disorders
by: Karen M. von Deneen, et al.
Published: (2023-06-01)

Neuropsychiatric Aspects of Huntington’s Disease
by: Özlem Devrim Balaban, et al.
Published: (2022-03-01)

Noteworthy perspectives on microglia in neuropsychiatric disorders
by: Hongrui Zhu, et al.
Published: (2023-10-01)

The Role of Tryptophan Metabolites in Neuropsychiatric Disorders
by: Majid Davidson, et al.
Published: (2022-09-01)

CB-SEM IMPLEMENTATION IN R AND PYTHON: A REVIEW AND COMPARATIVE STUDY
by: Souma Kanti Paul, et al.
Published: (2022-01-01)

Systems Bioinformatics Reveals Possible Relationship between COVID-19 and the Development of Neurological Diseases and Neuropsychiatric Disorders
by: Anna Onisiforou, et al.
Published: (2022-10-01)

Neuropsychiatric disorders correction in Alzheimer's disease
by: N. N. Koberskaya
Published: (2022-06-01)

Targeting CB2R in astrocytes for Parkinson's disease therapy: unraveling the Foxg1-mediated neuroprotective mechanism through autophagy-mediated NLRP3 degradation
by: Hong Zhu, et al.
Published: (2023-12-01)

Editorial: Interaction between neuropsychiatry and sleep disorders: From mechanism to clinical practice
by: Bin Zhang, et al.
Published: (2022-12-01)

Exosomes: potential targets for the diagnosis and treatment of neuropsychiatric disorders
by: Haorao Li, et al.
Published: (2024-01-01)

Editorial: Multi-dimensional characterization of neuropsychiatric disorders
by: Peng Wang, et al.
Published: (2022-12-01)

Editorial: Metabolic traits associated with neurodevelopmental and neuropsychiatric disorders
by: Rekha Jagadapillai, et al.
Published: (2023-11-01)

Celiac disease and neuropsychiatric disorders: A systematic review
by: Amina CHENTOUF, et al.
Published: (2022-05-01)

Dopaminergic Modulation of Synaptic Plasticity, Its Role in Neuropsychiatric Disorders, and Its Computational Modeling
by: Mojtaba Madadi Asl, et al.
Published: (2019-01-01)

Transdiagnostic Role of Glutamate and White Matter Damage in Neuropsychiatric Disorders: A Systematic Review
by: I. Luttenbacher, et al.
Published: (2022-06-01)

An adult case suggestive of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) diagnosis (tur)
by: Sare Aydın, et al.
Published: (2022-12-01)

A Comprehensive Evaluation of Cross-Omics Blood-Based Biomarkers for Neuropsychiatric Disorders
by: Weichen Song, et al.
Published: (2021-11-01)

Current Understanding of Moyamoya Disease (MMD) and Associated Neuropsychiatric Outcomes
by: Antonov A, et al.
Published: (2023-12-01)

Pharmacogenomics of Cognitive Dysfunction and Neuropsychiatric Disorders in Dementia
by: Ramon Cacabelos
Published: (2020-04-01)

The Histaminergic System in Neuropsychiatric Disorders
by: Li Cheng, et al.
Published: (2021-09-01)

Tibetan medicinal formulas used to treat neuropsychiatric disorders
by: Raquel de Luna Antonio, et al.
Published: (2012-06-01)

Anti-Inflammatory Activity of a CB2 Selective Cannabinoid Receptor Agonist: Signaling and Cytokines Release in Blood Mononuclear Cells
by: Antonella Capozzi, et al.
Published: (2021-12-01)

Involvement of an Aberrant Vascular System in Neurodevelopmental, Neuropsychiatric, and Neuro-Degenerative Diseases
by: Keiichi Ishihara, et al.
Published: (2023-01-01)

The Emergent Role of Virtual Reality in the Treatment of Neuropsychiatric Disease
by: Yacine Benyoucef, et al.
Published: (2017-09-01)

New Strategies for the Treatment of Neuropsychiatric Disorders Based on Reelin Dysfunction
by: Yumi Tsuneura, et al.
Published: (2022-02-01)

The Significance of NLRP Inflammasome in Neuropsychiatric Disorders
by: Yao Shen, et al.
Published: (2022-08-01)

Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets
by: Silvia Pasquini, et al.
Published: (2022-01-01)

Editorial: Animal models of neuropsychiatric disorders: validity, strengths, and limitations
by: Thibaut Sesia, et al.
Published: (2023-05-01)